Stay updated on AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Sign up to get notified when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.

Latest updates to the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded 'Small cell lung carcinoma' to the Conditions list in the study details.SummaryDifference0.0%

- Check35 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. The study details content and eligibility information appear unchanged.SummaryDifference0.0%

- Check42 days agoChange DetectedFooter now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check71 days agoChange DetectedAdded site revision banner "Revision: v3.4.2" and removed the previous "Revision: v3.4.1" banner (along with the funding-status notice). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check78 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center operations was added, and the page version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.